Last reviewed · How we verify

ParaGard® TCu380A — Competitive Intelligence Brief

ParaGard® TCu380A (ParaGard® TCu380A) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intrauterine contraceptive device (copper-based). Area: Contraception.

phase 3 Intrauterine contraceptive device (copper-based) Contraception Small molecule Live · refreshed every 30 min

Target snapshot

ParaGard® TCu380A (ParaGard® TCu380A) — FHI 360. ParaGard TCu380A is a copper-releasing intrauterine device that prevents pregnancy through copper ion toxicity to sperm and alteration of the uterine environment.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ParaGard® TCu380A TARGET ParaGard® TCu380A FHI 360 phase 3 Intrauterine contraceptive device (copper-based)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intrauterine contraceptive device (copper-based) class)

  1. FHI 360 · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ParaGard® TCu380A — Competitive Intelligence Brief. https://druglandscape.com/ci/paragard-tcu380a. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: